Citations for
1SCGB3A1
IFN-gamma down-regulates Secretoglobin 3A1 gene expression.
Yamada A, Suzuki D, Miyazono A, Oshima K, Kamiya A, Zhao B, Takami M, Donnelly RP, Itabe H, Yamamoto M, Kimura S, Kamijo R.
Biochem Biophys Res Commun 379(4):964-8. Epub 2009 Jan 9. 2009
2SCGB3A1
Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.
Guo M, Ren J, Brock MV, Herman JG, Carraway HE.
Epigenetics 3(6):336-41. Epub 2008 Nov 8. 2008
3CRABP1, HOXA9, HOXB5, SCGB3A1
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE.
Mol Cancer 6:45.PMID: 17623056 2007
4SCGB3A1
HIN-1, an inhibitor of cell growth, invasion, and AKT activation.
Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K.
Cancer Res 65(21):9659-69. 2005
5SCGB3A1
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.
Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K.
Mol Cancer Res 2(9):489-94. 2004
6SCGB3A1
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K.
Proc Natl Acad Sci U S A 98(17):9796-801. 2001